Sugi Predict

Sugi Predict / Compounds / SCHEMBL30361827

SCHEMBL30361827

SCHEMBL30361827

CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C

nearest known ligand 0.67

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 2/20 0.67
▸ NPY1R P25929 1/20 0.67
▸ NPY2R P49146 1/20 0.67
▸ NTSR2 O95665 3/20 0.51
▸ NTSR1 P30989 3/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ SORT1 Q99523 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31151549 0.97 NPY1R (0.64) NPY4RNPY1RNPY2R
SCHEMBL31151562 0.97 NPY1R (0.64) NPY4RNPY1RNPY2R
SCHEMBL30114882 0.97 NPY1R (0.69) NPY4RNPY1RNPY2RNTSR2NTSR1
SCHEMBL31151641 0.97 NPY1R (0.69) NPY4RNPY1RNPY2RNTSR2NTSR1
SCHEMBL30361862 0.96 NPY1R (0.65) NPY4RNPY1RNPY2R
SCHEMBL31151774 0.96 NPY1R (0.72) NPY4RNPY1RNPY2RNTSR2NTSR1
SCHEMBL31151720 0.96 NPY4R (0.65) NPY4RNPY1RNPY2RNTSR2NTSR1
SCHEMBL30361983 0.94 NPY1R (0.67) NPY4RNPY1RNPY2RNTSR2NTSR1
SCHEMBL31151681 0.90 BACE1 (0.54) NPY4RNPY1RNPY2RNTSR2NTSR1
SCHEMBL29961427 0.88 NPY1R (0.74) NPY4RNPY1RNPY2RNTSR2NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713002-A1 PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA Forssmann, Wolf-Georg (DE) 2026-03-25 — — EP disclosed
EP-4501348-A1 PEPTIDES FOR USE IN THE IMPROVEMENT OF WELL-BEING Forssmann, Wolf-Georg (DE) 2025-02-05 — — EP disclosed
EP-4501347-A1 PEPTIDES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Forssmann, Wolf-Georg (DE) 2025-02-05 — — EP disclosed
WO-2024235986-A1 PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA PHARIS BIOTEC GMBH (DE) 2024-11-21 — — WO disclosed
CN-105530948-B Peptides having antagonistic activity against natural CXCR4 法瑞斯生物技术有限公司 2023-05-26 — — CN disclosed